Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial von Haas, Naomi B, Dr, Manola, Judith, MS, Uzzo, Robert G, Prof, Flaherty, Keith T, MD, Wood, Christopher G, Prof, Kane, Christopher, Prof, Jewett, Michael, Prof, Dutcher, Janice P, Prof, Atkins, Michael B, Prof, Pins, Michael, Prof, Wilding, George, Prof, Cella, David, Prof, Wagner, Lynne, Prof, Matin, Surena, Prof, Kuzel, Timothy M, Prof, Sexton, Wade J, Prof, Wong, Yu-Ning, MD, Choueiri, Toni K, MD, Pili, Roberto, Prof, Puzanov, Igor, MD, Kohli, Manish, MD, Stadler, Walter, Prof, Carducci, Michael, Prof, Coomes, Robert, DiPaola, Robert S, Prof

Volltext

Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation von Lee, Joyce V., Carrer, Alessandro, Shah, Supriya, Snyder, Nathaniel W., Wei, Shuanzeng, Venneti, Sriram, Worth, Andrew J., Yuan, Zuo-Fei, Lim, Hee-Woong, Liu, Shichong, Jackson, Ellen, Aiello, Nicole M., Haas, Naomi B., Rebbeck, Timothy R., Judkins, Alexander, Won, Kyoung-Jae, Chodosh, Lewis A., Garcia, Benjamin A., Stanger, Ben Z., Feldman, Michael D., Blair, Ian A., Wellen, Kathryn E.

Volltext

Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma von Pal, Sumanta K, Sonpavde, Guru, Agarwal, Neeraj, Vogelzang, Nicholas J, Srinivas, Sandy, Haas, Naomi B, Signoretti, Sabina, McGregor, Bradley A, Jones, Jeremy, Lanman, Richard B, Banks, Kimberly C, Choueiri, Toni K

Volltext

Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial von SMITH, David C, SMITH, Matthew R, VAISHAMPAYAN, Ulka N, HAAS, Naomi B, SPIRA, Alexander I, LARA, Primo N, LIN, Chia-Chi, SRINIVAS, Sandy, SELLA, Avishay, SCHÖFFSKI, Patrick, SCHEFFOLD, Christian, WEITZMAN, Aaron L, SWEENEY, Christopher, HUSSAIN, Maha, ELFIKY, Aymen A, LOGOTHETIS, Christopher, CORN, Paul G, VOGELZANG, Nicholas J, SMALL, Eric J, HARZSTARK, Andrea L, GORDON, Michael S

Volltext

Adjuvant Vascular Endothelial Growth Factor–targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis von Sun, Maxine, Marconi, Lorenzo, Eisen, Tim, Escudier, Bernard, Giles, Rachel H., Haas, Naomi B., Harshman, Lauren C., Quinn, David I., Larkin, James, Pal, Sumanta K., Powles, Thomas, Ryan, Christopher W., Sternberg, Cora N., Uzzo, Robert, Choueiri, Toni K., Bex, Axel

Volltext

Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma von CHOUEIRI, Toni K, VAISHAMPAYAN, Ulka, OTTESEN, Lone H, LAUBSCHER, Kevin H, SHERMAN, Laurie, MCDERMOTT, David F, HAAS, Naomi B, FLAHERTY, Keith T, ROSS, Robert, EISENBERG, Peter, MELTZER, Paul S, MERINO, Maria J, ROSENBERG, Jonathan E, BOTTARO, Donald P, MARSTON LINEHAN, W, SRINIVASAN, Ramaprasad, LOGAN, Theodore F, HARZSTARK, Andrea L, BUKOWSKI, Ronald M, RINI, Brian I, SRINIVAS, Sandy, STEIN, Mark N, ADAMS, Laurel M

Volltext

Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial von Ninmer, Emily K., Zhu, Hong, Chianese-Bullock, Kimberly A., von Mehren, Margaret, Haas, Naomi B., Ross, Merrick I., Dengel, Lynn T., Slingluff, Craig L.

Volltext

Recent advances in localized RCC: A focus on VEGF and immuno-oncology therapies von Subramanian, Pearl, Haas, Naomi B.

Volltext

Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors von Piha-Paul, Sarina A, Hann, Christine L, French, Christopher A, Cousin, Sophie, Braña, Irene, Cassier, Phillippe A, Moreno, Victor, de Bono, Johann S, Harward, Sara Duckworth, Ferron-Brady, Geraldine, Barbash, Olena, Wyce, Anastasia, Wu, Yuehui, Horner, Thierry, Annan, Meg, Parr, Nigel J, Prinjha, Rabinder K, Carpenter, Christopher L, Hilton, John, Hong, David S, Haas, Naomi B, Markowski, Mark C, Dhar, Arindam, O’Dwyer, Peter J, Shapiro, Geoffrey I

Volltext

Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study von Smith, Matthew R, Sweeney, Christopher J, Corn, Paul G, Rathkopf, Dana E, Smith, David C, Hussain, Maha, George, Daniel J, Higano, Celestia S, Harzstark, Andrea L, Sartor, A Oliver, Vogelzang, Nicholas J, Gordon, Michael S, de Bono, Johann S, Haas, Naomi B, Logothetis, Christopher J, Elfiky, Aymen, Scheffold, Christian, Laird, A Douglas, Schimmoller, Frauke, Basch, Ethan M, Scher, Howard I

Volltext

Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805 von Jilaveanu, Lucia B, Puligandla, Maneka, Weiss, Sarah A, Wang, Xin Victoria, Zito, Christopher, Flaherty, Keith T, Boeke, Marta, Neumeister, Veronique, Camp, Robert L, Adeniran, Adebowale, Pins, Michael, Manola, Judith, DiPaola, Robert S, Haas, Naomi B, Kluger, Harriet M

Volltext

Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine von SLINGLUFF, Craig L, PETRONI, Gina R, CHIANESE-BULLOCK, Kimberly A, SMOLKIN, Mark E, ROSS, Merrick I, HAAS, Naomi B, MEHREN, Margaret Von, GROSH, William W

Volltext

Disease‐free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and... von Haas, Naomi B., Song, Yan, Willemann Rogerio, Jaqueline, Zhang, Su, Carley, Christopher, Zhu, JingJing, Bhattacharya, Rituparna, Signorovitch, James, Sundaram, Murali

Volltext

Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Tri... von Slingluff, Jr, Craig L, Petroni, Gina R, Olson, Walter C, Smolkin, Mark E, Ross, Merrick I, Haas, Naomi B, Grosh, William W, Boisvert, Marc E, Kirkwood, John M, Chianese-Bullock, Kimberly A

Volltext

Real‐world study on the characteristics, post‐nephrectomy journey, and outcomes of patients with early‐stage renal cell carcinoma based on risk groups von Karam, Jose A., Bhattacharya, Rituparna, Ogbomo, Adesuwa, Gautam, Santosh, Yu, Rebekah, Sundaram, Murali, Imai, Kentaro, Chhabra, Jatin, Haas, Naomi B.

Volltext

Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study von DORFF, Tanya B, FLAIG, Thomas W, VOGELZANG, Nicholas J, THOMPSON, Ian M, GLODE, L. Michael, TANGEN, Catherine M, HUSSAIN, Maha H. A, SWANSON, Gregory P, WOOD, David P, SAKR, Wael A, DAWSON, Nancy A, HAAS, Naomi B, CRAWFORD, E. David

Volltext

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER? von Patel, Hiten D, Puligandla, Maneka, Shuch, Brian M, Leibovich, Bradley C, Kapoor, Anil, Master, Viraj A, Drake, Charles G, Heng, Daniel Yc, Lara, Primo N, Choueiri, Toni K, Maskens, Deborah, Singer, Eric A, Eggener, Scott E, Svatek, Robert S, Stadler, Walter M, Cole, Suzanne, Signoretti, Sabina, Gupta, Rajan T, Michaelson, Marc Dror, McDermott, David F, Cella, David, Wagner, Lynne I, Haas, Naomi B, Carducci, Michael A, Harshman, Lauren C, Allaf, Mohamad E

Volltext

Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A) von Atkins, Michael B, Jegede, Opeyemi A, Haas, Naomi B, Mcdermott, David F, Bilen, Mehmet A, Stein, Mark, Sosman, Jeffrey, Alter, Robert, Plimack, Elizabeth R, Ornstein, Moshe C, Hurwitz, Michael, Peace, David J, Einstein, David, Catalano, Paul J, Hammers, Hans, Regan, Meredith M

Volltext

Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B) von Atkins, Michael B, Jegede, Opeyemi A, Haas, Naomi B, McDermott, David F, Bilen, Mehmet A, Stein, Mark, Sosman, Jeffrey A, Alter, Robert, Plimack, Elizabeth R, Ornstein, Moshe C, Hurwitz, Michael, Peace, David J, Signoretti, Sabina, Denize, Thomas, Cimadamore, Alessia, Wu, Catherine J, Braun, David, Einstein, David, Catalano, Paul J, Hammers, Hans

Volltext

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma von Choueiri, Toni K, Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Thomas, Chang, Yen-Hwa, Hajek, Jaroslav, Symeonides, Stefan N, Lee, Jae Lyun, Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Mahave, Mauricio, Haas, Naomi B, Sawrycki, Piotr, Gurney, Howard, Chevreau, Christine, Melichar, Bohuslav, Kopyltsov, Evgeniy, Alva, Ajjai, Burke, John M, Doshi, Gurjyot, Topart, Delphine, Oudard, Stephane, Hammers, Hans, Kitamura, Hiroshi, Bedke, Jens, Perini, Rodolfo F, Zhang, Pingye, Imai, Kentaro, Willemann-Rogerio, Jaqueline, Quinn, David I, Powles, Thomas

Volltext